Skip to main content
Clinical Trials/TCTR20210510005
TCTR20210510005RecruitingPhase 1

The Efficacy of Oropharyngeal Myofunctional Exercise as an Adjunct to Titratable Mandibular Advancement Device in Treating Obstructive Sleep Apnea Patients: A Randomized Controlled Trial

Chulalongkorn University0 sites30 target enrollmentStarted: May 10, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 100 Years (—)
Sex
All

Inclusion Criteria

  • 1.OSA patients diagnosed with laboratory polysomnography to have OSA and have been treating with MAD, 2.Age 18 years old or older, 3.Residual AHI is higher than 14 events per hour

Exclusion Criteria

  • 1.Patients with serious comorbidities such as moderate to severe pulmonary disease, neuromuscular disease, obesity hypoventilation syndrome, congestive heart failure, nocturnal arrythmias, 2.patients with other sleep disorders involved such as central sleep apnea, periodic limb movement disorder, insomnia, parasomnias, circadian rhythm disorders, narcolepsy, REM sleep behavioural disorder, 3.patients with painful TMD signs and symptoms according to DC/TMD, 4.patients on narcotics or muscle relaxants, 5.patients who had undergone oropharyngeal surgery, 6.patients with severe cognitive impairment

Investigators

Similar Trials

The Efficacy of Oropharyngeal... | Clinical Trial